Are patients with nonerosive gastroesophageal reflux disease at an increased risk of esophageal cancer compared with the average population?

A prospective cohort study followed more than 480,000 patients in Scandinavia for 32 years after undergoing endoscopy and found that nonerosive gastroesophageal reflux disease does not increase the likelihood of esophageal cancer. However, erosive gastroesophageal reflux disease is associated with a doubled, but still low, risk of developing cancer, with the likelihood increasing over time.

POEMs: No Increased Risk of Esophageal Cancer With Nonerosive Gastroesophageal Reflux; January 2024

What should be included when counseling individuals who desire a levonorgestrel intrauterine device?

Approximately 35% of patients with a levonorgestrel intrauterine device will experience frequent or prolonged bleeding in the first 3 months after insertion, but systematic reviews have shown that most patients will experience a reduction in bleeding within 12 months of use.